Latest News about LLY
Recent news which mentions LLY
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
From Motley Fool
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
December 21, 2023
From Motley Fool
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
December 20, 2023
From Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
From Benzinga
2 Unstoppable Growth Stocks to Buy in 2024
December 20, 2023
From Motley Fool
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
December 20, 2023
From Motley Fool
3 Top Dividend Stocks That Recently Hiked Their Payouts
December 20, 2023
From Motley Fool
Goldman Sachs: Eli Lilly's Shares May Surge By 140% With GLP-1 Drug Boom
December 19, 2023
Tickers
LLY
From Benzinga
Obesity/Diabetes Drug Class GLP-1s' Cost-Saving Potential: Decoding Impact on Healthcare Spending
December 18, 2023
From Benzinga
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
December 18, 2023
From Motley Fool
As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist?
December 18, 2023
From Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
From InvestorPlace
Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.
December 16, 2023
From Motley Fool
3 Stocks Wall Street Bulls Are Betting On Big-Time
December 15, 2023
From InvestorPlace
The New Magnificent 7: 7 Stocks Rising to Prominence
December 15, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
From Benzinga
Ozempic Isn't the Best Weight-Loss Treatment Anymore. Here's Why That Shouldn't Matter to Novo Nordisk Investors.
December 14, 2023
From Motley Fool
American Express, Eli Lilly, Humana And More: CNBC's 'Final Trades'
December 14, 2023
From Benzinga
From Benzinga
Nvidia, Disney and Tesla are among 2023’s buzziest stocks. Can they continue to sizzle in 2024?
December 13, 2023
From MarketWatch
LifeMD’s stock soars 13% as company and Medifast to create weight-management program that includes GLP-1 drugs
December 13, 2023
From MarketWatch
Weight Loss Drugs' Trickle Down Effect - Insurer Restrictions Create Access Challenges For Diabetes Patients
December 12, 2023
From Benzinga
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
December 12, 2023
From Motley Fool
Better Weight Loss Stock: Eli Lilly or Novo Nordisk?
December 12, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.